Patents Assigned to Quality Biological, Inc.
  • Publication number: 20020159984
    Abstract: In the art of tissue culture, it has been desired that serum-free culture conditions be found that support the growth and proliferation of hematopoeitic stem cells ex vivo. The present invention discloses a serum-free medium comprised, for example, of pharmaceutical grade components including pasteurized human proteins, that in the presence of the appropriate growth factors, supports the ex vivo maintenance, proliferation and/or differentiation of CD34+/CD38− cells derived from cord blood, mobilized peripheral blood or bone marrow. In conjunction with this effort, the ability of serum-free medium to maintain or cause proliferation of the HSCs ex vivo is assessed by their long-term engraftment in a chimeric sheep animal model.
    Type: Application
    Filed: April 30, 2002
    Publication date: October 31, 2002
    Applicant: Quality Biological, Inc.
    Inventor: Ronald Brown
  • Patent number: 6372210
    Abstract: A serum-free medium which supports the proliferation and differentiation of CD34+ cells purified from normal bone marrow, peripheral blood of patients treated with cytokines, and umbilical cord blood is described. The recipe for the formulation is given, which provides a medium suitable for the proliferation and differentiation of CD34+ cells for use in human therapeutic protocols. The cells CD34+ cultured in a the medium of the present invention are used in a method for repopulating human host bone marrow.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: April 16, 2002
    Assignee: Quality Biological, Inc.
    Inventor: Ronald L. Brown
  • Publication number: 20010014321
    Abstract: A serum-free medium which supports the proliferation and differentiation of CD34+cells purified from normal bone marrow, peripheral blood of patients treated with cytokines, and umbilical cord blood is described. The recipe for the formulation is given, which provides a medium suitable for the proliferation and differentiation of CD34+cells for use in human therapeutic protocols.
    Type: Application
    Filed: February 9, 2001
    Publication date: August 16, 2001
    Applicant: Quality Biological, Inc.
    Inventor: Ronald L. Brown
  • Patent number: 6224860
    Abstract: A serum-free medium which supports the proliferation and differentiation of CD34+ cells purified from normal bone marrow, peripheral blood of patients treated with cytokines, and umbilical cord blood is described. The recipe for the formulation is given, which provides a medium suitable for the proliferation and differentiation of CD34+ cells for use in human therapeutic protocols. The cells CD34+ cultured in a the medium of the present invention are used in a method for repopulating human host bone marrow.
    Type: Grant
    Filed: April 15, 1999
    Date of Patent: May 1, 2001
    Assignee: Quality Biological, Inc.
    Inventor: Ronald L. Brown
  • Patent number: 5945337
    Abstract: A serum-free medium which supports the proliferation and differentiation of CD34.sup.+ cells purified from normal bone marrow, peripheral blood of patients treated with cytokines, and umbilical cord blood is described. The recipe for the formulation is given, which provides a medium suitable for the proliferation and differentiation of CD34.sup.+ cells for use in human therapeutic protocols.
    Type: Grant
    Filed: October 17, 1997
    Date of Patent: August 31, 1999
    Assignee: Quality Biological, Inc.
    Inventor: Ronald L. Brown
  • Patent number: 5766951
    Abstract: A serum-free medium which supports the growth and proliferation of bone marrow cells is described. Recipes for two formulations are given, one of which provides a medium suitable for growth of bone marrow cells for use in human therapeutic protocols.
    Type: Grant
    Filed: November 12, 1992
    Date of Patent: June 16, 1998
    Assignee: Quality Biological, Inc.
    Inventor: Ronald L. Brown
  • Patent number: 5474894
    Abstract: A method for assaying the ability of an antibody to neutralize primary clinical isolates of human immunodeficiency virus (HIV) in primary human lymphocytes comprising the steps of contacting primary human lymphocytes with HIV and an antibody sample to be tested, without preincubating the antibody sample and the virus, culturing the primary human lymphocytes under conditions which allow for HIV replication without removal of the virus inoculum or antibody samples to be tested, and measuring HIV replication in the primary human lymphocytes by one or more of several conventional methods.
    Type: Grant
    Filed: January 21, 1994
    Date of Patent: December 12, 1995
    Assignee: Quality Biological, Inc.
    Inventor: Sandra K. Dusing
  • Patent number: 5371010
    Abstract: A method for cultivating eukaryotic cells, particularly bone marrow cells, which utilizes a gel system having a gel strength low enough to allow the cells to settle into the gel during cultivation. The gel system is preferably formed from a mixture of methylcellulose and modified agarose. Further, the gel system comprises a soft agar assay and kit for growing the bone marrow cells. The gel is transparent and is present in a single uniform layer with a thickness of 0.5 to 4 mm.
    Type: Grant
    Filed: February 8, 1994
    Date of Patent: December 6, 1994
    Assignee: Quality Biological, Inc.
    Inventors: Ronald L. Brown, Gretchen Schwartz
  • Patent number: 5336614
    Abstract: A kit and method for cultivating cells, particularly bone marrow cells, which utilizes a gel system having a gel strength low enough to allow the cells to settle into the gel during cultivation. The gel system is preferably formed from a mixture of methylcellulose and modified agarose.
    Type: Grant
    Filed: August 14, 1991
    Date of Patent: August 9, 1994
    Assignee: Quality Biological, Inc.
    Inventors: Ronald L. Brown, Gretchen Schwartz